GSK To End Doctor Payments To Market Meds

Law360, New York (December 17, 2013, 3:02 PM EST) -- British drug giant GlaxoSmithKline PLC said Tuesday that it will stop paying doctors and other health care professionals to speak about its drugs or go to medical conferences, in an announcement that comes amid a Chinese probe into its alleged bribes in China to boost drug sales. 

The company did not say whether the ongoing bribery probe in China — where its sales targets allegedly imposed pressure on salespeople to offer bribes — spurred the changes, citing only a push to change its business model to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.